Lilly to share in Evercore ISI HealthCONx Conference

Lilly to share in Evercore ISI HealthCONx Conference

Eli Lilly and Company( NYSE LLY) will attend the fifth periodic Evercore ISI HealthCONx Conference on Wednesday,Nov. 30, 2022. Jacob Van Naarden, Lilly administrative vice chairman and CEO ofLoxo@Lilly, and David Hyman,M.D., principal medical officer,Loxo@Lilly, will share in a domicile converse at 1210p.m., Eastern time.
A live audio webcast will be available on the” Webcasts & donations” section of Lilly’s Investor website at https//investor.lilly.com/webcasts-and-presentations. A renewal of the donation will be available on this same website for roughly 90 days.

About Lilly
Lilly unites minding with discovery to produce drugs that make life better for people around the world. We have been introducing life- changing discoveries for nearly 150 times, and moment our drugs help further than 47 million people across the globe. employing the power of biotechnology, chemistry and inheritable drug, our scientists are urgently advancing new discoveries to break some of the world’s most significant health challenges, reconsidering diabetes care, treating rotundity and abridging its most ruinous long- term goods, advancing the fight against Alzheimer’s complaint, furnishing results to some of the utmost enervating vulnerable system diseases, and transubstantiating the most delicate- to- treat cancers into manageable conditions. With each step toward a healthier world, we are motivated by one thing making life better for millions further people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to insure our drugs are accessible and affordable.

Source link:https://investor.lilly.com/